Negotiations on the inclusion of the Russian vaccine against coronavirus Sputnik V in the list of those approved by the World Organization may take several days, WHO spokesman Margaret Harris said at a briefing on Tuesday.
According to Harris, these discussions show that the world is at a reasonably good stage. But these debates will not necessarily end on this day. The permission to include into the list of drugs for use in emergencies will be given by experts only when they are satisfied with all the data, RIA Novosti reports.
The organization said the discussions would begin on January 22.
Russia has two approved vaccines against coronavirus Sputnik V, developed by the Gamaleya center, and EpiVacCorona, created by the Vector lab. The third drug by Chumakov Center of the Russian Academy of Sciences is coming soon.
At the end of December last year, the Russian Sputnik V vaccine received a foreign registration certificate. Belarus was the first state to approve this vaccine on its territory.
NEWS.ru reported earlier that Turkmenistan authorized the use of Russia's Sputnik V vaccine.